OAM
Origin Asset Management’s Biogen BIIB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-6,182
| Closed | -$1.75M | – | 97 |
|
|
2020
Q3 | $1.75M | Sell |
6,182
-6,318
| -51% | -$1.79M | 0.19% | 37 |
|
|
2020
Q2 | $3.34M | Sell |
12,500
-1,200
| -9% | -$321K | 0.49% | 24 |
|
|
2020
Q1 | $4.33M | Sell |
13,700
-19,500
| -59% | -$6.17M | 0.56% | 19 |
|
|
2019
Q4 | $9.85M | Hold |
33,200
| – | – | 0.82% | 26 |
|
|
2019
Q3 | $7.73M | Sell |
33,200
-5,900
| -15% | -$1.37M | 0.71% | 43 |
|
|
2019
Q2 | $9.14M | Sell |
39,100
-19,700
| -34% | -$4.61M | 1.02% | 32 |
|
|
2019
Q1 | $13.9M | Buy |
58,800
+11,800
| +25% | +$2.79M | 1.16% | 39 |
|
|
2018
Q4 | $14.1M | Sell |
47,000
-15,900
| -25% | -$4.78M | 1.29% | 30 |
|
|
2018
Q3 | $22.2M | Buy |
62,900
+25,500
| +68% | +$9.01M | 1.45% | 27 |
|
|
2018
Q2 | $10.9M | Sell |
37,400
-47,900
| -56% | -$13.9M | 0.77% | 54 |
|
|
2018
Q1 | $23.4M | Sell |
85,300
-7,200
| -8% | -$1.97M | 1.47% | 23 |
|
|
2017
Q4 | $29.5M | Sell |
92,500
-3,800
| -4% | -$1.21M | 1.69% | 21 |
|
|
2017
Q3 | $30.2M | Sell |
96,300
-2,700
| -3% | -$845K | 1.85% | 19 |
|
|
2017
Q2 | $26.9M | Hold |
99,000
| – | – | 1.65% | 22 |
|
|
2017
Q1 | $27.1M | Buy |
99,000
+5,750
| +6% | +$1.57M | 1.68% | 19 |
|
|
2016
Q4 | $26.4M | Buy |
93,250
+1,700
| +2% | +$482K | 1.74% | 15 |
|
|
2016
Q3 | $28.7M | Buy |
+91,550
| New | +$28.7M | 1.82% | 17 |
|
|
2015
Q3 | – | Sell |
-80,392
| Closed | -$32.5M | – | 103 |
|
|
2015
Q2 | $32.5M | Sell |
80,392
-6,989
| -8% | -$2.82M | 2.36% | 9 |
|
|
2015
Q1 | $36.9M | Buy |
87,381
+9,374
| +12% | +$3.96M | 2.72% | 4 |
|
|
2014
Q4 | $26.5M | Buy |
78,007
+4,807
| +7% | +$1.63M | 2.01% | 10 |
|
|
2014
Q3 | $24.2M | Buy |
+73,200
| New | +$24.2M | 1.57% | 25 |
|